SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that Felix J. Baker, Ph.D., has been appointed to the Company's Board of Directors. Dr. Baker is a managing partner of Baker Bros. Advisors, LLC, the manager and advisor to the funds of Baker Brothers Investments, Ardea's largest shareholder.
"Ardea's impressive accomplishments have made it an important company in our portfolio, so I am pleased to join the Board of Directors," commented Dr. Baker. "We look forward to becoming more actively involved in its continued success."
"Baker Brothers Investments has been a significant, long-term supporter of Ardea and has a well-deserved reputation for consistently understanding and backing high quality life sciences companies," commented Barry D. Quart, PharmD, Ardea's president and chief executive officer. "We are pleased to have Dr. Baker join our board and we look forward to his insights, guidance and support at what is an exciting time in Ardea's history."
About Baker Brothers Advisors, Baker Brothers Investments and Felix Baker
Baker Bros. Advisors, LLC is the manager and advisor to the funds of Baker Brothers Investments. Baker Brothers Investments, founded by Felix and Julian Baker in 2000, is a family of long-term investment funds for major endowments and foundations, which are focused on publicly traded life sciences companies. Felix Baker began his career as a fund manager by co- founding a biotechnology investment partnership in 1994. Felix Baker holds a B.S. and a Ph.D. in Immunology from Stanford University,
|SOURCE Ardea Biosciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved